Fluticasone + Umeclidinium + Vilanterol Trifenatate
Fixed-dose combination
This page lists brands whose active-ingredient set is exactly the combination below. It is identity information only — a fixed-dose combination is not the same product as its single ingredients, and the brand names are not interchangeable across markets.
Not medical advice. Check the pack and the exact composition before comparing products; ask a pharmacist if unsure.
Active ingredients
- Fluticasone
fluticasone - Umeclidinium
umeclidinium - Vilanterol Trifenatate
vilanterol-trifenatate
Brands with this exact combination
| Brand | Dose | Manufacturer |
|---|---|---|
| fluticasone furoate, umeclidinium bromide and vilanterol trifenatateUS | 0.1 mg / 0.0625 mg / 0.025 mg / 0.2 mg | GlaxoSmithKline LLC |
| TRELEGY ELLIPTA INHALATION POWDER 100 MCG/62.5 MCG/25 MCGSG | 0.1 mg / 0.0625 mg / 0.025 mg / 0.2 mg | GLAXOSMITHKLINE PTE LTD |
| TRELEGY ELLIPTA 100/62.5/25 fluticasone furoate 100 ug / umeclidinium (as bromide) 62.5 ug / vilanterol (as trifenatate) 25 ug powder for inhalationAU | 40 microgram / 74.2 microgram / 100 microgram / 200 microgram | GlaxoSmithKline Australia Pty Ltd |
| umeclidinium bromide + fluticasone furoate + vilanterol trifenatate + fluticasone furoate + vilanterol trifenatateAU | — | — |
Same combination in other markets
No product with this combination is recorded in the other covered markets yet.
Only the main ingredient is the same — this is NOT the same fixed-dose combination. View the main ingredient
See warnings for these ingredients
Source & licence: built from the same regulator data as the ingredient pages (openFDA, dm+d, CIMA, COFEPRIS, PBS/TGA, Health Canada DPD, NHSA). Facts only; see the licence register.